Dr. Keith M.K. Chong (PhD, MBA)

Startups don’t fail because of ideas; they fail because they run out of cash, lose operational focus, or struggle to access the right networks. That’s where I step in. I help healthcare and medtech companies bridge the gap from early-stage funding to real revenue, ensuring they are not only investable but ready to scale and enter new markets. My work combines strategic execution, operational leadership, and ecosystem access to turn innovation into measurable outcomes. How I Help Companies Succeed: 1. Bridging Early-Stage to Market Traction Guide healthcare startups and growth-stage companies in securing funding, structuring operations, and launching successfully in Southeast Asia. 2. Financial & Operational Health Platform Establish cash flow management, operational execution, and strategic planning that ensures startups and expansion projects deliver results; not just reports. 3. Ecosystem & Market Access Connect companies with investors, hospitals, distributors, government partners, and commercial channels, enabling fast, efficient market entry and partnership development. 4. Interim Leadership & Execution Act as Market Entry or Commercialisation Lead, taking ownership of SEA expansion, partnerships, and first revenue, so founders focus on product and growth while avoiding costly mistakes. I work with companies that need results fast, want local expertise, and are ready to pay for outcome-driven execution.

As Co-Founder and Chief Strategy & Research Officer of Shvanas Sdn Bhd, I help shape the company’s strategic direction, research agenda, and commercialisation pathways to advance innovation in pet wellness and preventative healthcare. Shvanas is a pet wellness and health innovation company focused on extending the quality and longevity of animal life through non-invasive therapeutic technologies, preventive care solutions, and integrated wellness services. The company combines science, technology, and compassion to redefine how pets are cared for across their lifespan. In this role, I: 1. Lead Strategic Direction and Commercial Expansion - Drive the company’s strategic priorities by identifying growth opportunities, structuring partnerships, and guiding market expansion initiatives across pet wellness, veterinary, and preventive care ecosystems. 2. Oversee Research, Clinical Insight & Innovation Development - Guide research and market validation efforts across pet health, including preventive care applications, therapeutic technologies, and competitive benchmarking to support evidence-based innovation and product positioning. 3. Build Partnerships and Ecosystem Access - Support the development of strategic collaborations with veterinary clinics, pet healthcare providers, distributors, and ecosystem partners to accelerate adoption and scale impact across key markets. 4. Drive Business Structuring and Commercialisation Strategy - Contribute to the structuring of new ventures, services, and commercial models, including investor-facing materials and expansion strategies that support sustainable scaling of pet wellness solutions. 5. Align Strategy with Scalability and Long-Term Impact - Provide strategic input on operational planning, scalability, and revenue growth while ensuring alignment with Shvanas’ mission of improving animal health outcomes through innovation, prevention, and compassionate care.

Syndesi Capital is a strategic consultant and facilitation platform supporting local and global investors as well as entrepreneurs. Key Focus Areas: 1. Assist investors and families on establishing and structuring Family Offices in Singapore, including ecosystem navigation and strategic positioning. 2. Support interested families in securing long-term residency through the Malaysia My Second Home (MM2H) program, integrating lifestyle, healthcare, and investment opportunities. 3. Facilitate introductions to private investment banks, wealth managers, and strategic partners in Singapore. 4. Originate and curate proprietary deal flow in healthcare, MedTech, and life sciences, connecting investors with high-quality opportunities aligned with regional growth trends. 5. Provide strategic guidance and coordination to companies preparing for IPOs in Singapore.

As an Advisory Board Member of 3DP4ME (3D Printing for the Middle East), I support a mission-driven humanitarian technology organisation dedicated to restoring mobility, dignity, and hope for children affected by conflict. 3DP4ME leverages advanced 3D printing technology to deliver affordable, high-quality prosthetics to children in conflict zones such as Syria and Gaza. The organisation has been recognised by the World Economic Forum, as well as global leaders including Intel and Accenture, for its innovation and impact. In this role, I: 1. Provide strategic and commercial advisory to support 3DP4ME’s growth, sustainability, and regional expansion. 2. Advise on the development of scalable impact models, including its innovative 1:1 for-profit structure that balances humanitarian outcomes with long-term viability. 3. Support partnerships with healthcare institutions, governments, NGOs, and industry partners to expand access and adoption. 4. Contribute insights across healthcare innovation, technology translation, and ecosystem building to strengthen operational execution. 5. Help guide the organisation toward its goal of fitting 50 patients per month in Syria, with future expansion across the Middle East. I am honoured to serve alongside a dedicated Advisory Board and to support the Founders of 3DP4ME, whose leadership and compassion continue to bring meaningful impact to children in some of the world’s most challenging environments. Thanks also for the opportunity from Veblen.

As Vice Chair, Global Strategy & Innovation Partnerships at ViroVita Foundation Inc, I lead the development of global strategy and cross-sector innovation partnerships to advance the Foundation’s mission in healthcare, life sciences, and global health impact. ViroVita Foundation operates at the intersection of scientific research, medical innovation, preventive healthcare, and global health systems, with a strong focus on translating science into scalable, accessible, and sustainable real-world solutions across international markets. In this role, I: 1. Lead global strategy development and long-term growth planning across programs, platforms, and partnerships. 2. Build and structure cross-sector innovation partnerships with research institutions, healthcare systems, industry players, and impact investors. 3. Drive the translation of scientific research into deployable clinical, public health, and community-based solutions. 4. Support international expansion, ecosystem building, and multi-country collaboration models. 5. Align innovation, commercial sustainability, and social impact to ensure scalable, long-term value creation. I work closely with the leadership team to ensure that innovation is not only scientifically strong, but operationally viable, globally scalable, and capable of delivering measurable outcomes for patients, healthcare systems, and communities worldwide.

As Chapter Director of VNTR in Singapore, I represent a global community of 5,000+ professional investors across VC funds, family offices, CVCs, and active LPs. VNTR connects investors through curated deal flow, co-investment syndicates, secondary opportunities, and an exclusive club focused on peer-to-peer learning and trusted collaboration. In this role, I: 1. Build and grow VNTR’s presence in Singapore, connecting the region’s vibrant venture capital ecosystem with our global investor network. 2. Organize high-impact investor events, roundtables, and masterminds to foster trust, insight-sharing, and co-investment opportunities. 3. Act as a super-connector, bringing together investors, founders, and strategic partners to accelerate access to capital and innovation. 4. Support members with access to high-quality deals and syndication through VNTR’s global platform. 5. Develop deep expertise in community building, business development, fundraising, and investor relations.

I invest in MRI because I see a powerful vision that is both rare and transformative — making healthcare accessible and affordable at a global scale. My approach as an investor goes beyond just funding; it’s about aligning with visionary founders who are driven by purpose and backed by the determination to change the status quo. What I Bring to the Table: 1. Strategic Insight: I provide more than just capital; I offer high-level strategic guidance, helping MRI navigate complex markets, scale operations, and identify growth opportunities that are aligned with global healthcare trends. 2. Network Leverage: I use my extensive network of industry leaders, partners, and investors to create unique opportunities, facilitating partnerships that unlock operational efficiencies and accelerate MRI's mission. 3. Founder-Centric Mentorship: True value in investing comes from supporting founders with the right vision. I’m deeply involved in helping them turn big ideas into actionable, impactful results by providing tactical advice, fostering collaboration, and ensuring their journey is as scalable as the innovations they’re bringing to market. As my second investment venture, MRI represents the type of company I believe in: one that pushes boundaries, defies industry norms, and creates real-world solutions. I’m drawn to working with bold, visionary founders because they are the ones who can shape industries and leave a lasting impact. If you believe you’re a great founder with a remarkable project, let’s talk. I understand the challenges and pain points of entrepreneurship, and I’m always looking for ways to help solve them. I’m here to support you, guide you, and help bring your vision to life. This partnership is about more than just capital. It’s about fostering a legacy of innovation, transformation, and a bold future for healthcare.

I mentor at the FI Caribbean Startup Accelerator because I believe that bold founders from emerging markets deserve the same shot at global impact as anyone else. The Caribbean is brimming with untapped potential, and I see the power of this program in equipping founders to turn raw ideas into scalable, world-changing ventures. For me, mentorship isn’t just about sharing knowledge — it’s about unlocking momentum, bridging ecosystems, and building lasting founder resilience. What I Bring to the Table: 1. Founder-Centric Mentorship - To guide founders through ambiguity, help them validate business models, sharpen their pitches, and make hard decisions with clarity and confidence. 2. Strategic & Market Insight- With a deep understanding of regional innovation ecosystems and global trends, I help startups localize wisely and scale purposefully. Whether it's refining go-to-market strategies or pressure-testing monetization, I bring a global investor lens to regional founders. 3. Ecosystem Connectivity - I open doors. From investors and regulators to corporate partners and international collaborators, I connect founders to the right people who can amplify their traction, unlock resources, or simply help them move faster. Being part of FI Caribbean allows me to empower entrepreneurs not just with frameworks — but with fire. If you're a founder hungry for progress and ready to challenge norms, I’m here to walk that journey with you. Let’s build startups that matter — not just for today, but for the future of the region and beyond.

As Board Director at UroMedTech, I am entrusted with strategic leadership to guide the company’s growth and innovation in the urology sector. My focus is on fostering sustainable development and cultivating impactful relationships with stakeholders, helping UroMedTech transition from promising beginnings to scaling new heights. Key Contributions: 1. Capital Strategy: Spearheading investor relations and capital acquisition efforts to secure funding for advancing healthcare technology. 2. Visionary Oversight: Collaborating with executive teams to align operational milestones with the company’s long-term mission of transforming urology care. 3. Stakeholder Engagement: Strengthening ties with investors and healthcare partners to champion innovation and accelerate market penetration. This role allows me to combine strategic foresight, fundraising acumen, and governance expertise to drive transformative impact in healthcare innovation. While focusing on my new venture to help more startups, I maintain as the minority shareholder in UroMedTech.

When I first started UroMedTech, many said it was impossible to get it done. But I took the helm and led the company through challenges to achieve significant milestones, including certifications from the Singapore Health Department for strategic approvals. We’ve made tremendous progress in a short period, and I couldn’t be prouder of the work we’ve accomplished. As Managing Director, I orchestrated UroMedTech’s journey from ideation to execution, focusing on both operational and strategic initiatives. From building a high-performing team to achieving regulatory milestones, I drove the company toward its vision of delivering impactful healthcare solutions. Key Achievements: 1. Product Excellence: Guided the full product development lifecycle, culminating in the prototyping and regulatory submission of the flagship product within a year. 2. ISO Certification: Achieved ISO 13485 certification, underscoring our commitment to quality and compliance. 3. Team Expansion: Scaled the team from 10 to 20 members, fostering a culture of collaboration and innovation. 4. Strategic Alliances: Secured government support and forged regional partnerships, enhancing scalability and market readiness. Drawing from my leadership experiences at Merck and StratifiCare, I successfully led UroMedTech’s evolution from zero to one, positioning it as a disruptive force in the healthcare landscape. At UroMedTech, I’ve had the privilege of blending visionary strategy with hands-on execution, creating a path of sustainable growth and impactful healthcare transformation with the team. Together, we are reimagining urology care with passion and precision, and proving that when you believe in your vision, the impossible becomes achievable.

At Creative Medtech Solutions, I was all about turning big ideas into game-changing innovations. In a world where it's either go big or go broke, I embraced the mindset that big visions come with big sacrifices. Here’s how I made it happen: 1. Game-Changing Product Roadmap: I took the lead in shaping both our short- and long-term product strategies. The goal? To always stay ahead of market needs and customer demands. By focusing on the most impactful features, I ensured our roadmap was agile and future-ready—allowing us to move quickly, adapt, and seize new opportunities as they came. 2. Expanding Our Horizons: I worked on growing our network and capabilities by connecting with top players in academia and industry. Whether it was setting up research partnerships with universities or bringing in cutting-edge tech, I helped our company stay at the forefront of innovation. These collaborations boosted our R&D and opened doors to new avenues for sales and distribution. 3. Building a Culture of Innovation: Success wasn’t just about strategy; it was about building a team and culture that thrived on continuous innovation and customer-first thinking. By fostering a mindset where new ideas were always encouraged, we set ourselves up for long-term success. 4. Big Vision, Big Sacrifice: In the pursuit of something truly transformative, we understood that big visions come with big sacrifices. It’s not easy, but it’s worth it when you’re building something that can change the game. Whether it’s taking risks or pushing the limits, I’ve always believed in aiming high and giving everything to make it a reality. I’m passionate about challenging the status quo and shaping the future of healthcare technology. Every step I took in this role was about making a lasting impact and driving change on a larger scale.

Studying overseas for the first time and without any Malaysian community support in NUS. It wasn’t easy, but I was fortunate to be introduced to Sheares Hall by a senior who is a son of my teacher from my school, SMK Seri Keledang. I always appreciate his help! During my 4 years at NUS, I joined the Special Programme in Sciences (SPS), which encouraged interdisciplinary studies—combining chemistry, mathematics, physics, and biology. It was here that I truly fell in love with science, thanks to the thought-provoking research approach and passion of my first professor, Dr. Claire. Apart from SPS, I spent 3 years in Sheares Hall, participating in various activities but most of the times spent helping establish the Malaysian Students League with my friend Thomas Wen Hau and a few friends. We eventually met Kim Wong, who turned it into a recognized society at NUS. On my third year onwards, I focused more on research and less on extracurriculars.

It is a joint program between IE Business School and SMU. The Intensive Online MBA was the perfect fit for my lifestyle while working at Merck, requiring me to travel nearly 70% of the time. Each day, I would wake up at 3-4 AM to complete assignments and submit them before heading into work. The unique blend of 1-2 weeks in Madrid and 3 weeks in Singapore, with the rest conducted online, made for a challenging yet rewarding experience. Despite the intensive nature, I managed to graduate after just 13 months. The support from my wife, incredible classmates and engaging professors made all the difference. The program equipped me with valuable knowledge and a broader perspective on the business world, which has been invaluable in my career.

It is a joint program between IE Business School and SMU. The Intensive Online MBA was the perfect fit for my lifestyle while working at Merck, requiring me to travel nearly 70% of the time. Each day, I would wake up at 3-4 AM to complete assignments and submit them before heading into work. The unique blend of 1-2 weeks in Madrid and 3 weeks in Singapore, with the rest conducted online, made for a challenging yet rewarding experience. Despite the intensive nature, I managed to graduate after just 13 months. The support from my wife, incredible classmates and engaging professors made all the difference. The program equipped me with valuable knowledge and a broader perspective on the business world, which has been invaluable in my career.

This wasn’t a full-time PhD for me, but a challenging part-time program while managing two different projects simultaneously. Project 1: STOP dengue grant. My role was to identify biomarkers—both host and viral—that could help differentiate patients at risk of severe dengue, allowing for timely medical intervention. PhD Project: My own research focused on understanding why the viral capsid protein localized in the nucleus of infected cells during replication. Managing both projects simultaneously taught me how to juggle responsibilities effectively, organize lab, maintain equipment like fluorescent microscopes, and troubleshoot experiments. The challenges were significant, but the rewards were immense. This period marked my learning curve for handling multiple projects, developing essential skills for managing a busy research lab, writing research article, book chapter and research grant as well as gaining a deeper understanding of molecular virology.